Richards, Merrill & Peterson’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Sell
67,275
-860
-1% -$5.7K 0.13% 137
2026
Q1
$353K Buy
68,135
+5,125
+8% +$32.1K 0.13% 140
2025
Q4
$461K Buy
63,010
+134
+0.2% +$1.3K 0.18% 118
2025
Q3
$627K Sell
62,876
-14,379
-19% -$159K 0.27% 97
2025
Q2
$699K Buy
77,255
+5,158
+7% +$33.6K 0.33% 79
2025
Q1
$463K Buy
72,097
+7,859
+12% +$69.9K 0.24% 97
2024
Q4
$611K Buy
+64,238
New +$564K 0.32% 78

Other funds holding ENVX

Richards, Merrill & Peterson's ENVX Position: Q2 2026 in Review

Richards, Merrill & Peterson reduced its Enovix (ENVX) stake by 1.3% in Q2 2026, selling an estimated $5.7K and leaving 67,275 shares worth $408K. The position accounts for 0.13% of the portfolio, ranked #137.

Richards, Merrill & Peterson first reported a position in ENVX in Q4 2024 and has held it in 7 quarters since. The position peaked at $699K in Q2 2025. 298 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • Richards, Merrill & Peterson held 67,275 shares of Enovix worth $408K as of Q2 2026.
  • Richards, Merrill & Peterson sold 860 Enovix shares in Q2 2026, an estimated $5.7K.
  • Enovix made up 0.13% of Richards, Merrill & Peterson's portfolio in Q2 2026, its #137 holding.
  • Richards, Merrill & Peterson first reported a position in Enovix in Q4 2024 and has held it in 7 quarters since.
  • Richards, Merrill & Peterson's Enovix position peaked at $699K in Q2 2025.
  • 298 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on Richards, Merrill & Peterson's 13F filing for Q2 2026, filed 16 Jul 2026.